Status:
COMPLETED
Pacemaker Therapy in Adults With Congenital Heart Defects
Lead Sponsor:
Emory University
Conditions:
Congenital Disorder
Eligibility:
All Genders
19+ years
Brief Summary
Review the feasibility, safety and outcomes in adults with congenital heart disease who undergo pacemaker implantation for bradycardia, tachycardia or heart failure indications
Detailed Description
Survival to adulthood is now common for children born with congenital heart defects (CHD). This improved survival is in large part due to advances in cardiac surgery over the past 4 decades. However, ...
Eligibility Criteria
Inclusion
- Congenital heart disease diagnosis
- Pacemaker implantation completed during the period of Jan. 1, 1996 to Dec. 1, 2005
- Age 18 to 80, inclusive
Exclusion
- Those who do not meet inclusion criteria
Key Trial Info
Start Date :
January 1 1996
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2006
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT00303511
Start Date
January 1 1996
End Date
August 1 2006
Last Update
August 8 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Emory University SOM Adult Cardiac Clinic
Atlanta, Georgia, United States, 30322